Journey Medical (DERM) EBITDA Margin (2020 - 2026)
Journey Medical's (DERM) quarterly EBITDA Margin came in at 9.37% in Q1 2026, up 1593.0% YoY from 0.55% in Q1 2025, and down 240.14% on a QoQ basis from 2.76% in Q4 2025.
Journey Medical (DERM) EBITDA Margin (2020 - 2026) Analysis & Trends
Journey Medical (DERM) has 7 years of EBITDA Margin data on file, last reported at 9.37% in Q1 2026.
- Quarterly EBITDA Margin rose 1593.0% year-over-year to 9.37% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 9.9% (up 261.0% YoY) and the FY2025 annual result came in at 13.21%, up 1160.0% from the prior year.
- EBITDA Margin retreated to 9.37% in Q1 2026, from 2.76% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 49.93% in Q3 2023 to a low of 78.59% in Q1 2023.
- A 5-year average of 24.55% and a median of 19.7% in 2024 frame the typical range for EBITDA Margin.
- The widest YoY moves for EBITDA Margin: up 10883 bps in 2023, down 7432 bps in 2023.
- Tracing DERM's EBITDA Margin over 5 years: stood at 62.78% in 2022, then soared by 78 bps to 13.79% in 2023, then jumped by 228 bps to 17.7% in 2024, then plunged by 116 bps to 2.76% in 2025, then plunged by 240 bps to 9.37% in 2026.
- The last three EBITDA Margin figures came in at 9.37% (Q1 2026), 2.76% (Q4 2025), and 8.98% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Journey Medical | 205.79 Mn | 180.15 Mn | 12.37 Mn | 2.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.46% |
| Mar 31, 2026 | -9.37% |
| Dec 31, 2025 | -2.76% |
| Sep 30, 2025 | -8.98% |
| Jun 30, 2025 | -19.16% |
| Mar 31, 2025 | -25.30% |
| Dec 31, 2024 | 17.70% |
| Sep 30, 2024 | -19.78% |
| Jun 30, 2024 | -19.70% |
| Mar 31, 2024 | -77.44% |
| Dec 31, 2023 | -13.79% |
| Sep 30, 2023 | 49.93% |
| Jun 30, 2023 | -45.12% |
| Mar 31, 2023 | -78.59% |
| Dec 31, 2022 | -62.78% |
| Sep 30, 2022 | -58.90% |
| Jun 30, 2022 | -39.05% |
| Mar 31, 2022 | -4.27% |
| Dec 31, 2021 | -51.70% |
| Sep 30, 2021 | -64.49% |